Cargando…

Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis

BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant tumors. In the present study, the expression profile of human multistage colorectal mucosa tissues, including healthy, adenoma, and adenocarcinoma samples was downloaded to identify critical genes and potential drugs in CRC. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Juan, Wang, Ziheng, Shen, Xianjuan, Cui, Xiaopeng, Guo, Yuehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625111/ https://www.ncbi.nlm.nih.gov/pubmed/31087508 http://dx.doi.org/10.1002/mgg3.713

Ejemplares similares

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
por: Wu, Qiong, et al.
Publicado: (2019)

Identification of Potential Biomarkers and Small Molecule Drugs for Cutaneous Melanoma Using Integrated Bioinformatic Analysis
por: Liu, Yong, et al.
Publicado: (2022)

Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis
por: Ma, Jilei, et al.
Publicado: (2021)

Identification of novel biomarkers and candidate small molecule drugs in rheumatoid arthritis and osteoarthritis based on bioinformatics analysis of high‐throughput data
por: Zuo, Bin, et al.
Publicado: (2020)

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy
por: Wei, Min, et al.
Publicado: (2022)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
por: Wang, Dongjiao, et al.
Publicado: (2022)

The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high‐throughput data
por: Zhang, Bo, et al.
Publicado: (2019)

Identification of Candidate Biomarkers for Idiopathic Thrombocytopenic Purpura by Bioinformatics Analysis of Microarray Data
por: Gilanchi, Samira, et al.
Publicado: (2020)

Identification of Drug-Induced Liver Injury Biomarkers from Multiple Microarrays Based on Machine Learning and Bioinformatics Analysis
por: Wang, Kaiyue, et al.
Publicado: (2022)

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
por: Yu, Liyan, et al.
Publicado: (2023)

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
por: Tang, Xin, et al.
Publicado: (2018)

Identification of small molecules that Enhance Synaptogenesis using Synapse Microarrays
por: Shi, Peng, et al.
Publicado: (2011)

Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme
por: Qi, Fuwei, et al.
Publicado: (2020)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Identification of Biologically Active, HIV TAR RNA-Binding Small Molecules Using Small Molecule Microarrays
por: Sztuba-Solinska, Joanna, et al.
Publicado: (2014)

Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis
por: Sun, Zhen, et al.
Publicado: (2021)

Integrated Microarray Analysis to Identify Genes and Small-Molecule Drugs Associated with Stroke Progression
por: Cui, Shasha, et al.
Publicado: (2022)

Identification of Potential Biomarkers and Small Molecule Drugs for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): An Integrated Bioinformatics Study Using Big Data
por: Balachandran, Kumarendran, et al.
Publicado: (2023)

Identification of candidate biomarkers of liver hydatid disease via microarray profiling, bioinformatics analysis, and machine learning
por: Peng, Jinwu, et al.
Publicado: (2021)

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
por: Guo, Tingting, et al.
Publicado: (2019)

Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis
por: Qiu, Hui-Zhu, et al.
Publicado: (2020)

Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus
por: Alur, Varun, et al.
Publicado: (2021)

Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis
por: Hao, Mingqian, et al.
Publicado: (2020)

Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
por: Li, Chengrui, et al.
Publicado: (2021)

Identification of novel key genes and potential candidate small molecule drugs in diabetic kidney disease using comprehensive bioinformatics analysis
por: Li, Bin, et al.
Publicado: (2022)

Probing Biology with Small Molecule Microarrays (SMM)
por: Winssinger, Nicolas, et al.
Publicado: (2007)

Identification of biomarkers for the diagnosis and treatment of primary colorectal cancer based on microarray technology
por: Zheng, Zhi Gang, et al.
Publicado: (2020)

Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses
por: Liu, Zhendong, et al.
Publicado: (2020)

Identification of novel methylated targets in colorectal cancer by microarray analysis and construction of co-expression network
por: Li, Dongsheng, et al.
Publicado: (2017)

Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis
por: Fan, Qiaowei, et al.
Publicado: (2017)

Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database
por: Xiao, Guan-Fa, et al.
Publicado: (2020)

Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis
por: Mi, Jing-Lin, et al.
Publicado: (2020)

Identification of hub genes and small-molecule compounds related to intracerebral hemorrhage with bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2019)

Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
por: Felsenstein, Kenneth M., et al.
Publicado: (2015)

A bioinformatics framework to identify the biomarkers and potential drugs for the treatment of colorectal cancer
por: Leng, Xiaogang, et al.
Publicado: (2022)

Identification of Potential microRNA Panels for Male Non-Small Cell Lung Cancer Identification Using Microarray Datasets and Bioinformatics Methods
por: Haranguș, Antonia, et al.
Publicado: (2022)

Bioinformatics analyses combined microarray identify the deregulated microRNAs in oral cancer
por: CUI, JING, et al.
Publicado: (2014)

Identification of the prognostic biomarkers and their correlations with immune infiltration in colorectal cancer through bioinformatics analysis and in vitro experiments
por: Guo, Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eju6hd65cc5rgkofjtul9k860a